Cg Oncology Inc (CGON)

EBITDA Margin

-3555.22%

TTM · Period ending:

CGON logo

CGON EBITDA Margin

Latest reported-3555.22%
CGON TTM EBITDA Margin (-20464.04% → -3555.22%)
High-resolution chart · PNG

CGON ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Cg Oncology Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-3,555.2184%
-3,638.0004%
-3,949.2574%
-6,940.5704%
-23,208.7114%
-15,937.3112%
-7,726.5145%
-10,572.9532%
-9,799.6923%
-10,466.0482%
-23,601.4706%
-20,464.0394%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.